
On March 1st, Fogcore Technology (Yueke RELX) saw a 16% increase in morning trading. As of the market close on March 1st, Fogcore Technology had risen 11.28% to $2.17 USD.
According to data, FogCore Technology's stock continuously declined in the past 3 days until a sudden rise on March 1st.
On the same day, the State Tobacco Monopoly Administration issued a notice regarding a special inspection on the regulation of the electronic cigarette market.
The National Tobacco Monopoly Bureau has announced that it will carry out a special inspection to regulate the electronic cigarette market. The inspection will focus on businesses that have not obtained the tobacco monopoly production license in accordance with the law, and will particularly investigate any illegal production and operation of e-cigarette nicotine, aerosols, e-cigarette products and other related activities after the end of the transition period on October 1st, 2022.
Companies that have obtained tobacco monopoly production licenses legally and engage in domestic production of electronic cigarettes will be inspected for the manufacture and sale of "flavored electronic cigarettes." The production of domestic electronic cigarette products that have not been through technical evaluation (or are being outsourced in the production process) will also be checked. Any irregular supply chain methods or sales activities that do not comply with regulations, as well as sales activities that have not been carried out through an electronic cigarette trading platform, will also be scrutinized.
The financial website "Finance World" speculates that the rise in FogCore Technology's stock on March 1 may be related to the recent special inspection.
Reference:
The tobacco monopoly bureau will carry out a special inspection to regulate the market order of electronic cigarettes. In early morning trading, Vape technology briefly rose by nearly 16%.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









